Impact of HMGB1/TLR ligand complexes on HIV-1 replication: Possible role for flagellin during HIV-1 infection

International Journal of Microbiology

Volumn , Issue , 2012, Pages

  Nowak, Piotr ^a   Abdurahman, Samir ^a   Lindkvist, Annica ^a   Troseid, Marius ^b   Sönnerborg, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863676731     PISSN: 1687918X     EISSN: 16879198     Source Type: Journal    
DOI: 10.1155/2012/263836     Document Type: Article

References (41)

1. Dinoso J. B., Kim S. Y., Wiegand A. M., Palmer S. E., Gange S. J., Cranmer L., O'Shea A., Callender M., Spivak A., Brennan T., Kearney M. F., Proschan M. A., Mican J. M., Rehm C. A., Coffin J. M., Mellors J. W., Siliciano R. F., Maldarelli F., Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy Proceedings of the National Academy of Sciences of the United States of America 2009 106 23 9403 9408
2. Hazenberg M. D., Otto S. A., Van Benthem B. H. B., Roos M. T. L., Coutinho R. A., Lange J. M. A., Hamann D., Prins M., Miedema F., Persistent immune activation in HIV-1 infection is associated with progression to AIDS AIDS 2003 17 13 1881 1888 (Pubitemid 37070273)
3. Hellerstein M., Hanley M. B., Cesar D., Siler S., Papageorgopoulos C., Wieder E., Schmidt D., Hoh R., Neese R., Macallan D., Deeks S., Mccune J. M., Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans Nature Medicine 1999 5 1 83 89 (Pubitemid 29051003)
4. Giorgi J. V., Hultin L. E., McKeating J. A., Johnson T. D., Owens B., Jacobson L. P., Shih R., Lewis J., Wiley D. J., Phair J. P., Wolinsky S. M., Detels R., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage Journal of Infectious Diseases 1999 179 4 859 870 (Pubitemid 29159331)
5. Deeks S. G., Phillips A. N., HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity Bratislava Medical Journal 2009 338, article a3172
6. Brenchley J. M., Price D. A., Douek D. C., HIV disease: fallout from a mucosal catastrophe? Nature Immunology 2006 7 3 235 239
7. Brenchley J. M., Douek D. C., The mucosal barrier and immune activation in HIV pathogenesis Current Opinion in HIV and AIDS 2008 3 3 356 361 (Pubitemid 351521021)
8. Brenchley J. M., Douek D. C., HIV infection and the gastrointestinal immune system Mucosal Immunology 2008 1 1 23 30
9. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection Nature Medicine 2006 12 12 1365 1371 (Pubitemid 44924494)
10. Baroncelli S., Galluzzo C. M., Pirillo M. F., Mancini M. G., Weimer L. E., Andreotti M., Amici R., Vella S., Giuliano M., Palmisano L., Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with 50 copies/ml HIV-1 RNA Journal of Clinical Virology 2009 46 4 367 370
11. Trseid M., Nowak P., Nystrm J., Lindkvist A., Abdurahman S., Snnerborg A., Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy AIDS 2010 24 11 1733 1737
12. Nowak P., Barqasho B., Treutiger C. J., Harris H. E., Tracey K. J., Andersson J., Snnerborg A., HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages Cytokine 2006 34 1-2 17 23 (Pubitemid 43817548)
13. Thierry S., Gozlan J., Jaulmes A., Boniface R., Nasreddine N., Strauss F., Maréchal V., High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells AIDS 2007 21 3 283 292 (Pubitemid 46175041)
14. Cassetta L., Fortunato O., Adduce L., Rizzi C., Hering J., Rovere-Querini P., Bianchi M. E., Alfano M., Poii G., Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines AIDS 2009 23 5 567 577
15. Nowak P., Barqasho B., Snnerborg A., Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection AIDS 2007 21 7 869 871 (Pubitemid 46573160)
16. Andersson U., Wang H., Palmblad K., Aveberger A. C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K. J., High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes Journal of Experimental Medicine 2000 192 4 565 570 (Pubitemid 30666257)
17. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J. H., Suffredini A. F., Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 2003 101 7 2652 2660 (Pubitemid 36857626)
18. Rouhiainen A., Tumova S., Valmu L., Kalkkinen N., Rauvala H., Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin) Journal of Leukocyte Biology 2007 81 1 49 58 (Pubitemid 46021252)
19. Hreggvidsdottir H. S., stberg T., Whmaa H., Schierbeck H., Aveberger A. C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H. E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation Journal of Leukocyte Biology 2009 86 3 655 662
20. Bianchi M. E., HMGB1 loves company Journal of Leukocyte Biology 2009 86 3 573 576
21. Ivanov S., Dragoi A. M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G. S., Wan Y., Biron C. A., Bianchi M. E., Wang H., Chu W. M., A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA Blood 2007 110 6 1970 1981 (Pubitemid 47443911)
22. Barqasho B., Nowak P., Abdurahman S., Walther-Jallow L., Snnerborg A., Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro Journal of General Virology 2010 91 7 1800 1809
23. Sitaraman S. V., Klapproth J. M., Moore D. A., Landers C., Targan S., Williams I. R., Gewirtz A. T., Elevated flagellin-specific immunoglobulins in Crohn's disease American Journal of Physiology 2005 288 2 G403 G406
24. Ziegler T. R., Luo M., Estvariz C. F., Moore D. A., Sitaraman S. V., Hao L., Bazargan N., Klapproth J. M., Tian J., Galloway J. R., Leader L. M., Jones D. P., Gewirtz A. T., Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome American Journal of Physiology 2008 294 2 R402 R410
25. Jiang W., Lederman M. M., Hunt P., Sieg C. F., Haley K., Rodriguez B., Landay A., Martin J., Sinclair E., Asher A. I., Deeks S. G., Douek D. C., Brenchley J. M., Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection Journal of Infectious Diseases 2009 199 8 1177 1185
26. Sandler N. G., Wand H., Roque A., Law M., Nason M. C., Nixon D. E., Pedersen C., Ruxrungtham K., Lewin S. R., Emery S., Neaton J. D., Brenchley J. M., Deeks S. G., Sereti I., Douek D. C., Plasma levels of soluble CD14 independently predict mortality in HIV infection Journal of Infectious Diseases 2011 203 6 780 790
27. Troseid M., Snnerborg A., Nowak P., High mobility group box protein-1 in HIV-1 infection: connecting microbial translocation, cell death and immune activation Current HIV Research 2011 9 1 6 10
28. Tian J., Avalos A. M., Mao S. Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L. L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M. K., Fitzgerald K. A., Latz E., Kiener P. A., Coyle A. J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nature Immunology 2007 8 5 487 496 (Pubitemid 46605917)
29. Vijay-Kumar M., Gewirtz A. T., Flagellin: key target of mucosal innate immunity Mucosal Immunology 2009 2 3 197 205
30. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R., Yi E. C., Goodlett D. R., Eng J. K., Akira S., Underhill D. M., Aderem A., The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 2001 410 6832 1099 1103 (Pubitemid 32391041)
31. Vijay-Kumar M., Aitken J. D., Gewirtz A. T., Toll like receptor-5: protecting the gut from enteric microbes Seminars in Immunopathology 2008 30 1 11 21 (Pubitemid 351178620)
32. Lodes M. J., Cong Y., Elson C. O., Mohamath R., Landers C. J., Targan S. R., Fort M., Hershberg R. M., Bacterial flagellin is a dominant antigen in Crohn disease Journal of Clinical Investigation 2004 113 9 1296 1306 (Pubitemid 39069929)
33. Vijay-Kumar M., Gewirtz A. T., Role of flagellin in Crohn's disease: emblematic of the progress and enigmas in understanding inflammatory bowel disease Inflammatory Bowel Diseases 2009 15 5 789 795
34. Gewirtz A. T., Navas T. A., Lyons S., Godowski P. J., Madara J. L., Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression Journal of Immunology 2001 167 4 1882 1885 (Pubitemid 32747491)
35. Funderburg N., Luciano A. A., Jiang W., Rodriguez B., Sieg S. F., Lederman M. M., Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis PLoS ONE 2008 3 4
36. Thibault S., Imbeault M., Tardif M. R., Tremblay M. J., TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells Virology 2009 389 1-2 20 25
37. Epple H. J., Schneider T., Troeger H., Kunkel D., Allers K., Moos V., Amasheh M., Loddenkemper C., Fromm M., Zeitz M., Schulzke J. D., Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients Gut 2009 58 2 220 227
38. Targan S. R., Landers C. J., Yang H., Lodes M. J., Cong Y., Papadakis K. A., Vasiliauskas E., Elson C. O., Hershberg R. M., Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease Gastroenterology 2005 128 7 2020 2028 (Pubitemid 40824710)
39. Kamat A., Ancuta P., Blumberg R. S., Gabuzda D., Serological markers for inflammatory bowel disease in aids patients with evidence of microbial translocation PLoS ONE 2010 5 11
40. Collin E., Li C.-S., Ma Z.-M., Overman H., Knight T., Shifts in proportions of higher-taxa bacterial orders measured by 16S rDNA PCR in the stools of HIV patients following ART and correlations with HIV immunopathogenesis Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections 2011 Boston, Mass, USA
41. Macnab R. M., How bacteria assemble flagella Annual Review of Microbiology 2003 57 77 100